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A rapid and sensitive analytical method was developed for the spectrophotometric assay of prazosin
hydrochloride. The method is based on the formation of a coloured derivative between the drug and
1,2-naphthoquinone-4- sulphonic acid sodium salt (NQS). The reaction proceeds quantitatively at pH
4.5 and 70◦ C for 40 min. After the extraction of the derivative with chloroform: n-butanol (3:1), the
absorbance was measured at 400 nm. The method was applied to commercially available tablets and the
results were statistically compared with those obtained by ultraviolet spectrophotometric and differential
pulse polarographic methods using t- and F-tests.
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Introduction
Prazosin (1) 1-(4-amino-6,7-dimethoxy-2-quizanolinyl)-4-(2-furanylcarbonyl) piperazine is an antihypertensive1
and a potent vasodilatory agent2 in the quinazoline family and also has been found to be value in the treatment of heart failure3 . The drug and its formulations are official in the British Pharmacopeia4 and United
States Pharmacopoeia5 .
There are fluorimetric6 , UV spectrophotometric7,8 , GLC9 , TLC10 , voltametric11,12, and differential
pulse polarographic13−15 methods in the literature for the assay of the drug. The official USP XXII method
uses a HPLC technique for the determination of 1 in capsules5 . There is no conventional method for the
tablets. HPLC is widely used for the assay of the drug in body fluids16−18 and biological samples19 . There
is only one visible-range spectrophotometric method20 in the literature, and so a simple, time-saving and
sensitive method for the assay of prazosin hydrochloride in pharmaceuticals and bulk sample formulations is
needed. This paper describes a spectrophotometric method based on the reaction of prazosin hydrochloride
with 1,2-naphthoquinone-4-sulphonic acid (NQS) via its amino group on the side chain attached to the
2-position of the dihydropyridine ring. NQS was previously reported to be a sensitive colour reagent for
several primary and secondary amines21−23.
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Experimental
Apparatus: A UNICAM UV2 UV/Visible spectrometer with 1 cm glass cells was used.
Chemicals: Pharmaceutical grade prazosin hydrochloride was kindly provided by Pfizer A.Ş. İstanbul,
Turkey, and Minipress tablets containing 1 mg prazosin hydrochloride/tablet were purchased. NQS and other
chemicals were purchased from Merck, Darmstadt, Germany. All solvents were analytical reagent grade and
water was distilled.
Reagent solution: 1% NQS solution in water was freshly prepared.
Buffer solution: 1.361 g potassium dihydrogen orthophosphate was dissolved in 75 mL water and the
solution pH adjusted to 4.5 with 0.1 M hydrochloric acid and diluted with water to 100 mL.
Standard solutions: A stock solution of 1 (1 mg/mL) was prepared using methanol. Standard solutions
were obtained by diluting the stock solutions with methanol for the preparation of the calibration curve in
the concentration range 40-200 .µg/mL.
Standard solution for UV-Spectrophotometric method: Stock solution containing 150 µg/mL of 1 was
prepared in 0.1 N CHCOOH: Methanol (30:70). Standard solutions (6-30 µg/mL concentration range) for
the preparation of the calibration curve were obtained by diluting the stock solution appropriately.
Sample solution: Thirty tablets were weighed and powdered. An accurately weighed portion of the
powdered tablets, equivalent to about 5 mg of prazosin hydrochloride, was shaken mechanically with about
15 mL of methanol for 30 min and diluted to 25 mL with methanol, and mixed and filtered.

Assay Procedure
Visible range spectrophotometric method
Into 20 mL glass stoppered centrifuge tubes were transferred 0.2-1.0 mL aliquots of standard solution and
3.0 mL of the sample solution. The volumes of standard solutions were completed to 1.0 mL and the volumes
of sample solutions to 3.0 mL with methanol. Then 1.0 mL of buffer solution and 0.6 mL of NQS solution
were added to each tube. The tubes were maintained at 70◦C in a water bath for 40 min. After cooling to
ambient temperature 5.0 mL of chloroform:n-butanol mixture (3:1) was added. The mixtures were vortexed
for 1 min and filtered through a 597 HY Rundfilter. The absorbances of the organic phases were measured at
400 nm against a blank solution. The amount of prazosin hydrochloride was calculated from the regression
equation of the calibration curve obtained by standard solutions.

UV-Spectrophotometric method (Reference method)
Thirty tablets were weighted and powdered. To a quantity of powder containing the equivalent of 5 mg of 1
was added 20-25 mL 0.1 N CH3 COOH: methanol (30:70) and transferred to a 50 mL volumetric flask. The
flask was agitated for 30 min and filled with the above mixture. The solution was filtered and the filtrate
was used in the UV-spectrophotometric determination after appropriate dilution. The absorption spectrum
of the diluted solution was recorded between 250 and 400 nm. The absorbance of the solution was measured
at λmax of 330.4 nm. The content of 1 was calculated from the corresponding calibration graph.
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Results and Discussion
The reaction between prazosin hydrochloride and NQS (Scheme) is a simple condensation reaction with the
elimination of NaHSO24
3 .
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Scheme. Reaction of prazosin hydrochloride (1) with NQS
Table 1. Effect of the pH on the reaction

pH
Absorbance

Chloride buffer
1.0
1.5
2.0
0.073 0.142 0.411

Acetate buffer
2.5
3.5
4.5
0.308
0.380

Phosphate buffer
4.0
4.5
5.5
0.598 0.695

The optimum conditions for the formation of yellow chromophore were investigated as a function of
pH and the type of the buffer, reaction temperature and time, the type of the extraction solvent and the
reagent amount. The effect of pH was studied in the range 1-5.5 because of several primary and secondary
amines give condensation reaction in the pH range 2-4.5. The maximum absorbance value was obtained
with pH 4.5 phosphate buffer (Table 1). The reaction was very slow at room temperature, and so the effect
of temperature and time on the reaction rate was examined in 60-80◦C interval (Table 2).
The reaction was completed in 40 min at 70◦ C. The lability of prazosin hydrochloride-NQ in aqueous
medium necessitated its extraction into the organic phase. Therefore chloroform, n-butanol, ethyl acetate,
methylisobutyl ketone (IBMK), acetonitril, and acetone, and chloroform:n-butanol (1:1), chloroform:nbutanol (3:1), chloroform:n-butanol (1:3), and n-butanol:ethyl acetate (2:1) solvent mixtures were tested
as extraction solvents and the maximum absorbance value was obtained with the chloroform:n-butanol (3:1)
solvent mixture at 400 nm. The colour intensity of prazosin hydrochloride-NQ was stable for more than 48
h in this solution.
Table 2. Effect of temperature and time on the reaction

Time(min)
60◦ C
Absorbance 70◦ C
80◦ C

10
0.629
0.581
0.597

20
0.629
0.580
0.598

30
0.633
0.608
0.590

40
0.633
0.820
0.590

50
0.633
0.581
0.568

60
0.824
0.580
0.568
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The optimum amount of reagent was determined by carrying out the reaction with 4.76.10−7 mole
of prazosin hydrochloride and 0.2-1.0 mL of 1% NQS solution; 0.6 mL of 1% NQS solution was enough
to complete the reaction (Table 3). The absorption spectrum of the coloured product produced by the
suggested procedure is shown in the Figure.
Table 3. Effect of the Amount of the Reagent

Standard NQS
Solution (mL)
(1% w/v)

0.2

0.4

0.6

0.8

1

Absorbance

0.448

0.59

0.696

0.589

0.593

Under these conditions a linear relationship existed between absorbance (A) and prazosine hydrochloride concentration (C) over the 40-200 µg.mL−1 range. The regression equation was
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Figure. Absorption spectra of Prazosin HCl- NQS derivative (—-) and its reagent blank (- - - -).

The method was applied to the determination of prazosine hydrochloride in commercially available
Minipress tablets and the results were compared with those obtained by UV-spectrophotometry (this method
was developed by Pfizer A.Ş.) and the differential pulse polarographic method13 (Table 4). There was no
significant difference between the proposed method and the reference methods.
In conclusion, the method described in this paper is suitable for the routine assay of prazosine
hydrochloride in pharmaceuticals. Although not as sensitive as chromatographic methods, it is an alternative
for the rapid and selective spectrophotometric determination in the UV region7 . The commonly used
excipients and additives in prazosin hydrochloride tablets such as talc (up to a 250-fold m/m excess compared
with PRH), starch (200-fold), boric acid (150-fold), stearic acid (60-fold) and propyl paraben (5-fold) did
not interfere in the method.
The proposed method has higher a λmax value and sensitivity. This is a decisive advantage since the
interference from the associated ingredients will be less at higher wavelengths than at lower wavelengths.
The results in Table 4 show that the proposed method can be applied for the analysis of pharmaceutical
preparations with considerable precision, accuracy and sensitivity. The procedure takes only 50 min and
does not require expensive solvents and reagents whereas chromatographic methods do.
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Table 4. Assay Results of Minipress Tablets (1 mg prazosin.HCl/tablet)

Statistical
Values

Described
Method

X
992.9
Recovery (%)
99.29
SD
14.7
SD%
1.48
N
5
t test of significance (p = 0.05, t = 2.31)
F test of significance (p = 0.05, F = 6.39)
∗

Reference Methods
Differential Pulse
Polarographic Method13
999.5
99.95
15.3
1.53
5
t = 0.62
F = 1.08

∗

UV-Spectrophotometric
Method7
987.1
98.71
10.6
1.07
5
t = 0.64
F = 1.92

λmax = 330.4 nm in methanol / 0.1 N CH3 COOH (7:3 v/v)
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